Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bristol-Myers Squibb Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bristol-Myers Squibb Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bristol-Myers Squibb Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bristol-Myers Squibb Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Bristol-Myers Squibb Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bristol-Myers Squibb Co, Medical Equipment, Deal Details 12
Venture Financing 12
Personal Genome Diagnostics Raises USD75 Million in Series B Financing 12
Grail Raises USD914 Million in First Tranche of Series B Financing 14
Partnerships 16
Bristol-Myers Squibb and Illumina Enter into Partnership Agreement 16
Guardant Health Enters into Agreement with Bristol-Myers 17
Bristol-Myers Squibb Plans to Enter into Research Agreement with GRAIL 18
HTG Molecular Diagnostics Amends Research Agreement with Bristol-Myers Squibb 19
SomaLogic Enters into Agreement with Bristol-Myers Squibb 20
Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 21
InCell Enters Into Co-Development Agreement With Bristol-Myers Squibb 22
Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 23
Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer’s Biomarkers 24
Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 25
Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb 26
Bristol-Myers Squibb Enters Into Co-Development Agreement With Meso Scale 27
Bristol-Myers Squibb Enters into Licensing Agreement with Enterome 28
Equity Offering 29
Nektar Therapeutics Raises USD850 Million in Private Placement of Shares 29
GeneCentric Diagnostics Raises Funds through Equity Financing 31
Debt Offering 32
Bristol-Myers Squibb Raises USD750 Million in Public Offering of 1.6% Notes Due 2019 32
Bristol-Myers Squibb Raises USD750 Million in Public Offering of 3.25% Notes Due 2027 34
Bristol-Myers Squibb Completes Public Offering Of 2% Senior Unsecured Notes Due 2022 For US$750 Million 36
Bristol-Myers Squibb Completes Public Offering Of Senior Unsecured Notes Due 2017 For US$750 Million 38
Bristol-Myers Squibb Completes Public Offering Of 3.25% Senior Unsecured Notes Due 2042 For US$500 Million 40
Acquisition 42
Bristol-Myers Rumored To Acquire Biogen Idec 42
Bristol-Myers Squibb Co – Key Competitors 43
Bristol-Myers Squibb Co – Key Employees 44
Bristol-Myers Squibb Co – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Joint Venture 52
Recent Developments 53
Strategy And Business Planning 53
Nov 01, 2017: Bristol-Myers Squibb, BioLabs Announce Founding Sponsorship in Support of Promising Biotech Companies in New York 53
Financial Announcements 54
Jul 26, 2018: Bristol-Myers Squibb Reports Second Quarter Financial Results 54
Feb 05, 2018: Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results 56
Oct 26, 2017: Bristol-Myers Squibb Reports Third Quarter Financial Results 58
Jul 27, 2017: Bristol-Myers Squibb Reports Second Quarter Financial Results 60
Apr 27, 2017: Bristol-Myers Squibb Reports First Quarter Financial Results 63
Jan 26, 2017: Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results 66
Corporate Communications 69
Sep 14, 2018: Bristol-Myers Squibb statement on resignation of Dr. José Baselga 69
Aug 28, 2018: Bristol-Myers Squibb names Christopher Boerner as executive vice president and chief commercial officer 70
Jul 23, 2018: Bristol-Myers Squibb announces resignation of Murdo Gordon as Chief Commercial Officer 71
Mar 01, 2018: Bristol-Myers Squibb Names Jose Baselga, M.D., Ph.D. to Board of Directors 72
Oct 09, 2017: Bristol-Myers Squibb Appoints Saurabh Saha, M.D., Ph.D., as Senior Vice President, Global Head of Translational Medicine 73
Sep 13, 2017: Bristol-Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors 74
Apr 10, 2017: Bristol-Myers Squibb Earns ENERGY STAR Partner of the Year Award for Third Consecutive Year 75
Mar 08, 2017: Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer 76
Feb 21, 2017: Bristol-Myers Squibb Appoints Three New Independent Directors 78
Government and Public Interest 79
May 02, 2018: 2cureX’s CEO Ole Thastrup will join Folkemodet 2018 in Denmark 79
Other Significant Developments 80
Aug 09, 2018: HTG Molecular announces amendment to second statement of work with QIAGEN Manchester 80
Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre 81
Appendix 82
Methodology 82
About GlobalData 82
Contact Us 82
Disclaimer 82
Bristol-Myers Squibb Co, Medical Equipment, Key Facts, 2017 2
Bristol-Myers Squibb Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bristol-Myers Squibb Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bristol-Myers Squibb Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bristol-Myers Squibb Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bristol-Myers Squibb Co, Deals By Market, 2012 to YTD 2018 9
Bristol-Myers Squibb Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Personal Genome Diagnostics Raises USD75 Million in Series B Financing 12
Grail Raises USD914 Million in First Tranche of Series B Financing 14
Bristol-Myers Squibb and Illumina Enter into Partnership Agreement 16
Guardant Health Enters into Agreement with Bristol-Myers 17
Bristol-Myers Squibb Plans to Enter into Research Agreement with GRAIL 18
HTG Molecular Diagnostics Amends Research Agreement with Bristol-Myers Squibb 19
SomaLogic Enters into Agreement with Bristol-Myers Squibb 20
Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 21
InCell Enters Into Co-Development Agreement With Bristol-Myers Squibb 22
Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb 23
Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer's Biomarkers 24
Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 25
Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb 26
Bristol-Myers Squibb Enters Into Co-Development Agreement With Meso Scale 27
Bristol-Myers Squibb Enters into Licensing Agreement with Enterome 28
Nektar Therapeutics Raises USD850 Million in Private Placement of Shares 29
GeneCentric Diagnostics Raises Funds through Equity Financing 31
Bristol-Myers Squibb Raises USD750 Million in Public Offering of 1.6% Notes Due 2019 32
Bristol-Myers Squibb Raises USD750 Million in Public Offering of 3.25% Notes Due 2027 34
Bristol-Myers Squibb Completes Public Offering Of 2% Senior Unsecured Notes Due 2022 For US$750 Million 36
Bristol-Myers Squibb Completes Public Offering Of Senior Unsecured Notes Due 2017 For US$750 Million 38
Bristol-Myers Squibb Completes Public Offering Of 3.25% Senior Unsecured Notes Due 2042 For US$500 Million 40
Bristol-Myers Rumored To Acquire Biogen Idec 42
Bristol-Myers Squibb Co, Key Competitors 43
Bristol-Myers Squibb Co, Key Employees 44
Bristol-Myers Squibb Co, Subsidiaries 46
Bristol-Myers Squibb Co, Joint Venture 52
List of Figures
Bristol-Myers Squibb Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bristol-Myers Squibb Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bristol-Myers Squibb Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bristol-Myers Squibb Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bristol-Myers Squibb Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bristol-Myers Squibb Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Bristol-Myers Squibb Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bristol-Myers Squibb Co, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
